Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$15M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 32 most recent Form 4 transactions.
| Aug 5 | APGE | Apogee Therapeutics, Inc. | MEXER◷ | 4,125 | $22.86 | $94.3K | +2.4% | Open the original filing on SEC.gov |
| Jul 14 | APGE | Apogee Therapeutics, Inc. | GGIFT | 8,000 | — | — | -4.5% | Open the original filing on SEC.gov |
| Jul 1 | APGE | Apogee Therapeutics, Inc. | MEXER◷◆ | 4,125 | — | — | — | Open the original filing on SEC.gov |
| Jul 1 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 5,500 | $132.74 | $730.1K | -3.0% | Open the original filing on SEC.gov |
| Jul 1 | APGE | Apogee Therapeutics, Inc. | MEXER◷ | 4,125 | $22.86 | $94.3K | +2.3% | Open the original filing on SEC.gov |
| Jun 22 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 26,400 | $132.60 | $3.5M | -12.8% | Open the original filing on SEC.gov |
| Jun 12 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 12,583 | $70.11 | $882.2K | -24.5% | Open the original filing on SEC.gov |
| Jun 11 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 22,417 | $70.13 | $1.6M | -30.4% | Open the original filing on SEC.gov |
| Jun 3 | APGE | Apogee Therapeutics, Inc. | MEXER◷◆ | 4,125 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 5,500 | $78.71 | $432.9K | -2.6% | Open the original filing on SEC.gov |
| Jun 3 | APGE | Apogee Therapeutics, Inc. | MEXER◷ | 4,125 | $22.86 | $94.3K | +2.0% | Open the original filing on SEC.gov |
| Jun 2 | ORKA | Oruka Therapeutics, Inc. | AGRANT◆ | 9,136 | — | — | — | Open the original filing on SEC.gov |
| May 21 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 11,667 | — | — | — | Open the original filing on SEC.gov |
| May 21 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 11,904 | — | — | — | Open the original filing on SEC.gov |
| May 21 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 38,689 | — | — | — | Open the original filing on SEC.gov |
| May 21 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 13,235 | $59.97 | $793.7K | -15.2% | Open the original filing on SEC.gov |
| May 21 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 53,447 | $59.10 | $3.2M | -38.1% | Open the original filing on SEC.gov |
| May 21 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 38,318 | $58.43 | $2.2M | -21.4% | Open the original filing on SEC.gov |
| May 21 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 11,667 | $11.77 | $137.3K | +7.0% | Open the original filing on SEC.gov |
| May 21 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 11,904 | $7.80 | $92.9K | +7.7% | Open the original filing on SEC.gov |
| May 21 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 38,689 | $6.84 | $264.6K | +33.2% | Open the original filing on SEC.gov |
| May 6 | APGE | Apogee Therapeutics, Inc. | MEXER◷◆ | 4,125 | — | — | — | Open the original filing on SEC.gov |
| May 6 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,800 | $84.60 | $152.3K | -0.9% | Open the original filing on SEC.gov |
| May 6 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 3,700 | $83.92 | $310.5K | -1.7% | Open the original filing on SEC.gov |
| May 6 | APGE | Apogee Therapeutics, Inc. | MEXER◷ | 4,125 | $22.86 | $94.3K | +2.0% | Open the original filing on SEC.gov |
| Apr 1 | APGE | Apogee Therapeutics, Inc. | MEXER◷◆ | 4,125 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 100 | $85.89 | $8.6K | <0.1% | Open the original filing on SEC.gov |
| Apr 1 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 2,702 | $85.33 | $230.6K | -1.3% | Open the original filing on SEC.gov |
| Apr 1 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 2,698 | $84.31 | $227.5K | -1.3% | Open the original filing on SEC.gov |
| Apr 1 | APGE | Apogee Therapeutics, Inc. | MEXER◷ | 4,125 | $22.86 | $94.3K | +2.0% | Open the original filing on SEC.gov |